About Mind Pharma

Mind Pharmaceuticals is a Clinical Asset Stage Company based in New Haven, CT that will target unmet needs in the CNS space with an initial focus on Treatment Resistant Depression and Headache Disorders.

Mission

To democratize mental health and well being

Management Team

Krishna P. Ravindranathan, PhD
Founder & CEO

Founder Genome Shield Diagnostics
Postdoc Yale Pharmacology, School of Medicine with Joseph Schlessinger
Postdoc, Yale Chemistry with Bill Jorgensen
Ph.D, Rutgers University, Computational Biochemistry

Prakash K Mandgi
Co-founder & CFO

Managing Director, Collaborator Inc
Ex Director Investment Banking, Midtown Partners
Over 15 years of Investment Banking Experience
Participated in transactions over $500M in various capacities
MBA University of Chicago, MS Biomedical Engineering CWRU

Scientific Advisory Board

Christopher Pittenger, MD, PhD
Chairman of Scientific Advisory Board

Elizabeth Mears and House Jameson Professor of Psychiatry, Yale
Director, Yale Program for Psychedelic Science, Psychiatry;
Deputy Chair for Translational Research, Psychiatry;
Director, Clinical Neuroscience Research Unit, Psychiatry;
Director, Yale Center for Brain and Mind Health, Yale School of Medicine;
Director, Yale OCD Research Clinic, Psychiatry;
Director, Neuroscience Research Training Program, Yale Department of Psychiatry
Fellow of the American College of Neuropsychopharmacology, the American Psychiatric Association, and the American Neurological Association.
MD and Ph.D. Columbia University

Kristin Murray
Head of Regulatory Affairs, CMC & Quality

Sr. VP, Head of Regulatory Consulting Services  Syner - G Biopharm Group (Over 30 years experience, Contributed >30 INDs/CTAs and marketing applications across multiple therapeutic areas including neurological, product types and global regions.)
Ex. Head of Regulatory and Quality of Xalud, Ultragenix and Shire Pharmaceuticals 
Ex. Director Global Regulatory Affairs Pfizer - Biotech
MA in Biochemistry, Harvard University
BS Biochemistry, Bates College

Board of Directors